U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.
Oncologist
; 20(11): 1320-5, 2015 Nov.
Article
in En
| MEDLINE
| ID: mdl-26446239
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Approval
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2015
Document type:
Article
Affiliation country: